- Home
- TRSG vs PYPD Comparison
TRSG vs PYPD Comparison
Compare TRSG & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- PYPD
- Stock Information
- Founded
- TRSG 1996
- PYPD 2008
- Country
- TRSG Singapore
- PYPD Israel
- Employees
- TRSG N/A
- PYPD N/A
- Industry
- TRSG
- PYPD Medical/Dental Instruments
- Sector
- TRSG
- PYPD Health Care
- Exchange
- TRSG NYSE
- PYPD Nasdaq
- Market Cap
- TRSG 25.8M
- PYPD 26.7M
- IPO Year
- TRSG 2024
- PYPD 2020
- Fundamental
- Price
- TRSG $1.90
- PYPD $2.80
- Analyst Decision
- TRSG
- PYPD Strong Buy
- Analyst Count
- TRSG 0
- PYPD 2
- Target Price
- TRSG N/A
- PYPD $10.50
- AVG Volume (30 Days)
- TRSG 14.5K
- PYPD 37.2K
- Earning Date
- TRSG 05-14-2025
- PYPD 05-14-2025
- Dividend Yield
- TRSG N/A
- PYPD N/A
- EPS Growth
- TRSG N/A
- PYPD N/A
- EPS
- TRSG N/A
- PYPD N/A
- Revenue
- TRSG $12,810,249.00
- PYPD N/A
- Revenue This Year
- TRSG N/A
- PYPD N/A
- Revenue Next Year
- TRSG N/A
- PYPD N/A
- P/E Ratio
- TRSG N/A
- PYPD N/A
- Revenue Growth
- TRSG N/A
- PYPD N/A
- 52 Week Low
- TRSG $1.00
- PYPD $2.30
- 52 Week High
- TRSG $5.16
- PYPD $4.67
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- PYPD 52.30
- Support Level
- TRSG N/A
- PYPD $2.44
- Resistance Level
- TRSG N/A
- PYPD $3.00
- Average True Range (ATR)
- TRSG 0.00
- PYPD 0.25
- MACD
- TRSG 0.00
- PYPD -0.01
- Stochastic Oscillator
- TRSG 0.00
- PYPD 42.86
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.